by Anubha Sinha on  March 6, 2014 at 6:07 PM Drug News
 Dr Reddy’s Launches Cheaper Version of Antibiotic Avelox in US
Dr Reddy's Laboratories said that after a nod from United States Food & Drug Administration (USFDA) it has launched Moxifloxacin Hydrochloride Tablets 400 mg in the US.

In the US, Moxifloxacin will be the cheaper version of antibiotic drug Avelox, which is manufactured by Bayer AG and distributed by Merck. The other two firms with approval of this drug are Teva and Aurobindo Pharma.

According to IMS Health, for the year ending December 2013 Avelox brand had US sales of approximately $195 mn.

Last week, Dr Reddy's Laboratories launched anti-migraine sumatriptan injection in the US which clocked $169-million sales in 2013.

Moxifloxacin is an antibiotic which is used for treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.

Source: Medindia

Most Popular on Medindia